Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Satoshi Kayukawa"'
Diagnosis of a SMARCA4‐deficient undifferentiated tumor using multigene panel testing: A case report
Autor:
Yoshiaki Marumo, Takashi Yoshida, Kenji Ina, Naohiro Matsunaga, Yuki Furukawa, Ayumi Kamiya, Takae Kataoka, Satoshi Kayukawa
Publikováno v:
Clinical Case Reports, Vol 11, Iss 9, Pp n/a-n/a (2023)
Key Clinical Message SMARCA4‐deficient thoracic carcinoma is a malignant tumor that may present as cancer of unknown primary. This tumor is refractory and requires a novel approach. In addition to identifying therapeutic targets, multigene panel te
Externí odkaz:
https://doaj.org/article/1e4f7ca5b3b040fcb2042bac839133f7
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 6, Iss 1, Pp 1-10 (2020)
Abstract Background We collaborated with the regional pharmaceutical associations near Nagoya Memorial Hospital and created a communication sheet for pharmaceutical cooperation between the hospital and health insurance pharmacies. Methods The communi
Externí odkaz:
https://doaj.org/article/7b0205f0ce8e4c66b7a8e7e757e0f2c6
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/c362d536a0a84e3987a9a95995d79f86
Publikováno v:
Medical Sciences, Vol 4, Iss 2, p 8 (2016)
Gastric cancer is the third leading cause of cancer-related mortality worldwide. Systemic chemotherapy is the main treatment option for advanced gastric cancer when the tumor is inoperable. Despite recent advances in chemotherapeutic agents, the prog
Externí odkaz:
https://doaj.org/article/b28d15273dbd4a3f9aca43430654a3a6
Publikováno v:
Haematologica, Vol 92, Iss 1 (2007)
Class II major histocompatibility complex (MHC II) is normally silenced in plasma/multiple myeloma (MM) cells at the transcriptional level through downregulation of class II transactivator (CIITA), allowing MM cells to escape from immunological respo
Externí odkaz:
https://doaj.org/article/a4d798f0e6bc479d920b06d2feb5096b
Autor:
Kenji Ina, Yuko Kato, Kengo Nanya, Satoshi Hibi, Yuko Shirokawa, Tomoko Toda, Satoshi Kayukawa
Publikováno v:
Journal of Cancer Research Updates. 12:1-4
Background: Remarkable progress in cancer genomic medicine (CGM) has been made with the advent of next-generation sequencing and advanced computational data analysis approaches. In Japan gene panel testing has been covered by the National Health Insu
Autor:
Satoshi Hibi, Kenji Ina, Shu Yuasa, Nobuto Ito, Yuko Shirokawa, Kengo Nanya, Yuko Kato, Takashi Yoshida, Satoshi Kayukawa
Publikováno v:
Journal of Cancer Research Updates. 11:78-82
The reactivation of the hepatitis B virus (HBV) following systemic chemotherapy reportedly caused acute liver dysfunction as a fatal complication. HBV reactivation sometimes occurs even after the cessation of chemotherapy, especially in the patients
Autor:
Shu Yuasa, Megumi Kabeya, Satoshi Hibi, Yuko Shirokawa, Chiaki Tokoro, Ryuichi Furuta, Seiji Nagao, Satoshi Kayukawa, Yoshiteru Tanaka, Kenji Ina
Publikováno v:
Journal of Analytical Oncology. 11:40-44
Epidermal growth factor receptor (EGFR) has received significant attention for its therapeutic potential for pain relief. The relief of neuropathic pain after treatment with anti-EGFR antibodies or tyrosine kinase inhibitors has been previously descr
Autor:
Yoshiaki Marumo, Takashi Yoshida, Yuki Furukawa, Kenji Ina, Ayumi Kamiya, Takae Kataoka, Satoshi Kayukawa
Publikováno v:
Clinical & Experimental Vaccine Research; Oct2023, Vol. 12 Issue 4, p319-327, 9p
Autor:
Satoshi Hibi, Yuko Shirokawa, Kengo Nanya, Yuko Kato, Nobuto Ito, Takae Kataoka, Takashi Yoshida, Yoshiaki Marumo, Satoshi Kayukawa, Shu Yuasa, Yoshiteru Tanaka, Kenji Ina
Publikováno v:
Journal of Analytical Oncology. 10:61-68
Background: Immune checkpoint inhibitors (ICIs) sometimes cause immune-related adverse events (irAEs), the timing of occurrence of which is difficult to predict. We created a system to safely manage the patients treated with ICIs who visit hospital d